Is Botox a treatment option to treat Migraines?: A Case Study
Kim L. Capehart, DDS, MBA, PhD
University of Phoenix, School of Advanced Studies, USA
Private Practice, Simpsonville, South Carolina, USA
: Dent Health Curr Res
Abstract
With a prevalence of 15-20% worldwide, migraine is the third most common disease. Migraine episodes are the most common complaint that leads patients to seek medical care. The treatment of migraine includes various medications depending on acute or preventative therapy. In the past decade the use of using botulinum Toxin Type A (BoNT-A) or Botox® has gained momentum in the treatment of many pain disorders including migraine headaches. Many studies have shown that treatment of migraines with Botox® have marked improvements when other treatment modalities have failed. The following case report presents a successful case implementing BoNT-A in the treatment plan for a patient suffering from migraine headaches. drkim@drcapehart.com